IPIC Message Board - Msg: 5608767

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

0.0%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (1244)	8/27/1998 8:34:00 PM
From: JMarcus	Read Replies (1) of 1359

I noticed that the Aug. 21 issue of The Kiplinger Washington Letter mentions IPIC's CerAxon as among three "[n]ew drugs that minimize strike damage and improve prospects for full recovery [and that] will be OK'd within the next 18 months to two years." It describes CerAxon as "A 'neuroprotective' that stimulates chemicals in the body linked to learning and memory." The other two drugs mentioned are Glaxo's GL150526 and Knoll's Viprinex.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next